Fig. 5: Event-free survival of AML patients according to the establishment of AML-PDX. | Nature Communications

Fig. 5: Event-free survival of AML patients according to the establishment of AML-PDX.

From: Comparison of clonal architecture between primary and immunodeficient mouse-engrafted acute myeloid leukemia cells

Fig. 5: Event-free survival of AML patients according to the establishment of AML-PDX.The alternative text for this image may have been generated using AI.

Kaplan–Meier estimates of event-free survival in 76 newly diagnosed AML patients according to the engraftment status in NOG mice. P-values were estimated from the Log-rank test. Source data are provided as a Source Data file.

Back to article page